(Q46170156)

English

A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder

scientific article published in March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder (English)

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Frank C Schieber

1

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

David W Boulton

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

Alfred H Balch

3

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

Robert Croop

4

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

Suresh Mallikaarjun

5

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

Jeannine Benson

6

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

Berit X Carlson

7

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

publication date

1 March 2009

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

Human Psychopharmacology

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

24

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

2

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

145-152

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of aripiprazole and concomitant lithium and valproate

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of randomized, controlled clinical trials in acute mania

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamotrigine-induced severe cutaneous adverse reactions.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of the use of typical antipsychotic agents in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevation of prolactin levels by atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.999

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.999

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

1 reference

Europe PubMed Central

20 December 2017

http://europepmc.org/abstract/MED/19132712

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46170156&oldid=2143899905"